
Prescription Drug New Retail "Internet+" Development Platform Provider

Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
SPH Health Commerce, as a leading enterprise in the innovative drug off-hospital market services, has built a multi-dimensional service system around the CTS business sector.In terms of Yi Medicine clinical trial services, comprehensive supply and supporting services are provided, including management services such as drug procurement, packaging services, warehousing, and logistics.To efficiently meet clinical needs.
Among them,In the procurement and supply of reference preparations, diverse procurement models, integrated procurement approaches, and a secure and reliable quality management system ensure the traceability and safety of pharmaceuticals.On this basis,Its professional logistics—GSP services further enhance distribution capabilities, offering time-limited door-to-door precise transportation, customized personalized logistics solutions, and full-chain logistics monitoring and supervision.Ensure full compliance from warehousing to end-users.
In addition,For the pharmaceutical storage环节, SPH Health Commerce operates a 2600㎡ GSP-certified warehouse (including cool storage, ambient storage, and cold storage), equipped with a 24-hour temperature and humidity monitoring system and the "Cold Chain Hub" cloud-based temperature control platform, supporting real-time cloud data synchronization and anomaly alerts., build an intelligent warehousing system. Currently, SPH Health Commerce has partnered withMore than 20 leading enterprises, including Roche, GSK, MSD, Simcere, Hengrui, CTTQ, and Qilu Pharmaceutical, have reached strategic cooperation.Fully demonstrates its professional recognition in the field of clinical trial services, establishing a leading position in the industry with full-cycle service capabilities and resource integration strengths.
Looking ahead, SPH Health Commerce looks forward to cooperating with more industry-leading enterprises. Through complementary advantages, resource sharing, and collaborative innovation, it aims to jointly enhance the management level of clinical trial drug supply in China and inject new momentum into promoting the high-quality development of the industry.